medigraphic.com
ISSN 0016-3813 (Impreso)

2002, Número S1

<< Anterior Siguiente >>

Gac Med Mex 2002; 138 (S1)


Linfomas extraganglionares

I. Linfoma nasal angiocéntrico
II. Linfoma primario gástrico
III. Linfoma de testículo
IV. Linfomas primarios del sistema nervioso central

Figueroa-Sandoval JF, Avilés-Miranda A, Cervera-Cevallos EE, Labardini-Mendez J

Idioma: Español
Referencias bibliográficas: 40
Paginas: 118-125
Archivo PDF: 58.63 Kb.


FRAGMENTO

Introducción

Linfomas extraganglionares

Un estudio internacional de frecuencia de cáncer registró en base a datos de mortalidad, que la tasa de incidencia ajustada de linfoma en México junto con otros países de América Central fue de 9.0x10 en mujeres para 1985 según Parkin.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Parkin DM, Pisan P. Estimates Of the worldwide incidence of eighteen major cancer in 1985: Int. J Cancer 1993; 54: 594-606.

  2. Dirección General de Epidemiología. Registro Historpatológico de Neoplasias Malignas en México. Morbilidad y Mortalidad. Bienio 1993-1994. Tendencias 1985-1994. México: Secretaría de Salud, México 1996.

  3. Mohar A, Sobrevilla P. Velásquez W. Linformas. Rev Invest Clin 1997;49: 56-63.

  4. Itami J, Itami M, Mikata A, et al. Non-Hodgkin’s lymphoma confined to the nasal cavity. Its relationship to the polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 1991;20:797-802.

  5. Cheong MC, Chau JKL, Law WH, et al. Primary non-Hodgkin’s of the nose and nasopharynx . J Clin Oncol 1998;16:70-77.

  6. Kwong YL, Chan ACL, Liang R, et al. CD56+ lymphomas. Br J Haematol 1997;88:821-829.

  7. Avilés A, Ródriguez L, Guzmán R, et al. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol 1992;10:141-145.

  8. Avilés A, Díaz NR, Neri N, et al. Angiocentric nasal T/NK cell lymphoma. Clin Lab Haematol 2000;22:215-220.

  9. Shikama N, Ikeda H, Nakamura S, et al. Localized aggressive non-Hodgkin’s lymphoma of the nasal cavity. A survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2001;51:1228-1233.

  10. Ribaut R, Haji E, Girinsky JA, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma.Leukemia 2000: 15: 1123-1126.

  11. Kiego H, Ho CJ, Ickyo W, et al. Angiocentrioc lymphoma of the head and neck. Patterns of systemic relapse after radiation therapy. J Clin Oncol 2000;18:54-63.

  12. Avilés A, Delgado S, Fernández A, et al.: Combined therapy in angioimmunoproliferative lesions . Eur J Cancer 1994; 30B:302-304.

  13. Sobrevilla CP, Meneses A, Alfaro R, et al. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma. Acta Oncol 1993;32:69-72.

  14. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin´s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-37.

  15. Zucca E, Cavalli F. Extranodal lymphomas. Ann Oncol 2000; 11(suppl 3): 219-22.

  16. Ibrahim E, Ezzat A, Roja M, Rahal M. Primary gastric non-Hodgkin´s lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma Ann Oncol 1999;10: 1441-49.

  17. Isaacson PG. Gastric MALT lymphoma: for concept to cure. Ann Oncol 1999; 10: 637-45.

  18. Wotherspoon AC, Ortiz-HidalgoC, Falzan MR, et al. Helicobacter pylori-associated gastritis and primary B cell gastric lymphoma. Lancet 1991;338:1175-76.

  19. Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphoma? Ann Oncol 1997;8:419-21.

  20. Harris NL, Jaffe ES, Stein, et al. A revised European -American Classification of Lymphoid Neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.

  21. Alpen B, Thiede C, Wundish T, et al. Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori erradication therapy. Clini Lymph 2001; Sept: 103-8.

  22. Starostik P, Patzner J, Greiner A, Schwarz S, Kalla J, Ott G, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002; 99:3-9.

  23. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with high incidence of extranodal recurrence. Cancer 2000;88:154-61.

  24. Gospodarowicz MK, Zucca E. Primary testis lymphoma: presentation, treatment, patterns of failure, and outcomes. Proceedings Asco, 2001:281-5.

  25. Lagrange JL, Ramaioli A, Theodore CH, et al. Non-Hodgkins lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol 2001;12:1313-9.

  26. Leite KR, Garicochea B, Srougi M, et al. Monoclonality of asynchronous bilateral lymphoma of the testis. Eur Urol 2000;38:774-7.

  27. Figueroa Sandoval J, F. Briseño Torres R, Peña P, Aguilar López L. Linfoma Primario del Sistema Nervioso Central(Experiencia del H.E.C.M.O)Revista de Hematología 2001;2:6-8.

  28. De Angelis LM. Current management of primary central nervous system lymphoma. Oncology1995;9:63-71.

  29. Helle TD et al. Primary central nervous system lymphoma clinopathological study of experience at Standford Journal of Neurosurgery 1981;60:94-103.

  30. Pollack JF, Lunsford LD, Flickinger JC. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989;63:939.

  31. Laperriere NJ, Cerezo L, Melosevic MF et al. Primary lymphoma of brain: results of management of a modern cohort with radiation therapy. Radiother-Oncol 1997;43:247-52.

  32. Blay JY, Ongolo Zogo P, Sebban C. Primary cerebral lymphoma: unsolved issues regarding first line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. Ann Oncol 2000;11:39-44.

  33. Reni M, Ferreri AJ, Guha Thakurta N, Yves Blay J et al. Clinical relevance of consolidation radiotherapy and other main Therapeutic issues in primary central nervous system lymphomas treated with upfront high dose methotrexate. Int J. Radiation Oncology Biol Phys 2001;51:419-425.

  34. Skarin AT ,Zuckerman KS, Pitman SN. High dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin´s lymphoma including CNS involmente Blood 1977;50:1039-1047.

  35. Abrey LE, Yahalom J, De Angelis LM. Treatment for primary CNS lymphoma: The next step. J. Clin Oncol 2000;18:3144-50.

  36. Cher L,Glass J,Harsh GR et al.Therapy of primary CNS lymphoma with methotrexate based chemotherapy and deferred radiotherapy:preliminary results.Neurology 1996;46:1757.

  37. De Angelis LM, Yahalom J, Thaler HT, et al. Combined modality therapy for primary CNS lymphoma. J. Clin. Oncol 1992;10:635-43.

  38. Sandor V, Stark-Vancs, Pearson D. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J. Clin Oncol 1998;16:3000-6.

  39. Nelson DF, Mart KL, Bonner H et al. Non-Hodgkin´s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the RTOG8315. International Journal of Radiation Oncology Biology and Physic 1992;23:9-17.

  40. Bessell EM, Graus F, López Guillermo, Villa S et al. CHOD/BVAM. Regimen plus radiotherapy in patient with primary CNS Non Hodgkin´s lymphoma. Int. J. Radiation Oncology Biol Phys 2001;50:457-464.




2020     |     www.medigraphic.com